Neutrophil dysfunction induced by hyperglycemia: Modulation of myeloperoxidase activity

Cell Biochemistry and Function

Volumn 30, Issue 7, 2012, Pages 604-610

  de Souza Ferreira, Cláudia ^a   Araújo, Tomaz Henrique ^b   Ângelo, Marilene Lopes ^a   Pennacchi, Paula Commune ^a   Okada, Sabrina Sayori ^c   de Araújo Paula, Fernanda Borges ^a   Migliorini, Silene ^c   Rodrigues, Maria Rita ^a  

^a Faculdade de Ciências e Tecnologia de Unaí FACTU   (Brazil)

^b FEDERAL UNIVERSITY OF ALFENAS   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Microbicidal; Myeloperoxidase; Phagocytosis; ROS; Type 1 diabetes

Indexed keywords

ALLOXAN; CHLORIDE; CYTOCHROME C; MYELOPEROXIDASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ALLOXAN DIABETES MELLITUS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANDIDA ALBICANS; CELL DEATH; CELL FUNCTION; CELL KILLING; CHEMOLUMINESCENCE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; FUNGAL STRAIN; GIEMSA STAIN; HYPERGLYCEMIA; IMMUNOFLUORESCENCE; MALE; MAY GRUNWALD GIEMSA STAINING; MICROBIAL ACTIVITY; MICROSCOPY; NEUTROPHIL; NONHUMAN; PERITONEUM; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; WESTERN BLOTTING;

ANIMALS; CANDIDA ALBICANS; HYPERGLYCEMIA; HYPOCHLOROUS ACID; LUMINESCENT MEASUREMENTS; MALE; NADPH OXIDASE; NEUTROPHILS; PEROXIDASE; PHAGOCYTOSIS; RATS; RATS, WISTAR;

CANDIDA ALBICANS; RATTUS;

EID: 84866986076     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.2840     Document Type: Article

References (44)

1. + flux. Nature 2002; 416: 291-297.
2. Roos D, van Bruggen R, Meischl C. Oxidative killing of microbes by neutrophils. Microbes Infect 2003; 5: 1307-1315.
3. Babior BM. The leukocyte NADPH oxidase. Isr Med Assoc J 2002; 4: 1023-1024.
4. Hampton MB, Kettle AJ, Winterbourn CC. Inside the neutrophil phagosome: Oxidants, myeloperoxidase and bacterial killing. Blood 1998; 92: 3007-3017.
5. Aratani Y, Kura F, Watanabe H, et al. Relative contributions of myeloperoxidase and NADPH-oxidase to the early host defense against pulmonary infections with Candida albicans and Aspergillus fumigatus. Med Mycol 2002; 40: 557-563.
6. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444: 860-867.
7. Kempf K, Rose B, Herder C, et al. The metabolic syndrome sensitizes leukocytes for glucose-induced immune gene expression. J Mol Med 2007; 85: 389-396.
8. Goh SY, Cooper ME. Clinical review: The role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab 2008; 93: 1143-1152.
9. Peleg AY, Weerarathna T, McCarthy JS, Davis TM. Common infections in diabetes: pathogenesis, management and relationship to glycaemic control. Diabetes Metab Res Rev 2007; 23: 3-13.
10. Vlassara H. The AGE-receptor in the pathogenesis of diabetic complications. Diabetes Metab Res Rev 2001; 17: 436-443.
11. Jabbour SA. Cutaneous Manifestations of Endocrine Disorders: A Guide for Dermatologists. Am J Clin Dermatol 2003; 4: 315-331.
12. Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 2001; 50: 537-546.
13. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
14. Jones OT, Hancock T. Assays of plasma membrane NADPH oxidase. Methods Enzymol 1994; 233: 222-229.
15. Rodrigues MR, Rodriguez D, Russo M, Campa A. Macrophage activation includes high intracellular myeloperoxidase activity. Biochem Biophys Res Commun 2002; 292: 869-873.
16. Weiss SJ, Klein R, Slivka A, Wei M. Chlorination of Taurine by Human Neutrophils. J Clin Invest 1982; 70: 598-607.
17. Sousa-e-Silva MCC, Sampaio SC, Borelli P, Curi R, Cury Y. Crotalus durissus terrificus snake venom regulates macrophage metabolism and function. J Leukoc Biol 2001; 70: 551-558.
18. Souza IP, Kang HC, Nardinelli L, Borelli P. Desnutrição protéica: efeito sobre o espraiamento, fagocitose e atividade fungicida de macrófagos peritoneais. Braz J Pharm Sci 2001; 37: 143-151.
19. Islam LN, Nabi AHMN. Endotoxins of Enteric Pathogens Modulate the Functions of Human Neutrophils and Lymphocytes. J Biochem Mol Biol 2003; 36: 565-571.
20. Otton R, Carvalho CR, Mendonca JR, Curi R. Low proliferation capacity of lymphocytes from alloxan-diabetic rats: involvement of high glucose and tyrosine phosphorylation of Shc and IRS-1. Life Sci 2002; 71: 2759-2771.
21. Baggiolini M, Dewald B, Moser B. Human chemokines: an update. Annu Rev Immunol 1997; 15: 675-705.
22. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989; 320: 365-376.
23. Moore PL, Bank HL, Brissie NT, Spicer SS. Phagocytosis of bacteria by polymorphonuclear leukocytes: a freeze-fracture, scanning electron microscope, and thin section investigation of membrane structure. J Cell Biol 1978; 76: 158.
24. Underhill DM, Ozinsky A. Phagocytosis of microbes: complexity in action. Annu Rev Immunol 2002; 20: 825-852.
25. Kettle AJ, Winterbourn CC. The influence of superoxide on the production of hypochlorous acid by human neutrophils. Free Radic Res Commun 1991; 12: 47-52.
26. Gasbarrini A, Pasini P, Nardo B, et al. Chemiluminescent Real Time Imaging of Post-Ischemic Oxygen Free Radicals Formation in Livers Isolated From Young and Old Rats. Free Radic Biol Med 1998; 24: 211-216.
27. Winterbourn CC, Vissers MC, Kettle AJ. Myeloperoxidase. Curr Opin Hematol 2000; 7: 53-58.
28. Hampton MB, Kettle AJ, Winterbourn CC. Inside the neutrophil phagosome: Oxidants, myeloperoxidase and bacterial killing. Blood 1998; 92: 3007-3017.
29. Baldus S, Heeschen C, Meinertz T, et al. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 2003; 108: 1440-1445.
30. Daugherty A, Dunn J, Rateri D, Heinecke J. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest 1994; 94: 437-444.
31. Zhang R, Brennan ML, Fu X, et al. Association between myeloperoxidase levels and risk of coronary artery disease. JAMA 2001; 286: 2136-2142.
32. Meuwese MC, Stroes ES, Hazen SL, et al. Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study. J Am Coll Cardiol 2007; 50: 159-165.
33. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-820.
34. Ikeda K, Higashi T, Sano H, et al. N-(epsilon)-(carboxymethyl)lysine protein adduct is a major immunologicalepitope in proteins modified with advancedglycation end products of the Maillard reaction. Biochemistry 1996; 35: 8075-8083.
35. Ahmed MU, Brinkmann FE, Degenhardt TP, Thorpe SR, Baynes JW. N-epsilon-(carboxyethyl) lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. Biochem J 1997; 324: 565-570.
36. Ashman RB, Farah CS, Wanasaengsakul S, Hu Y, Pang G, Clancy RL. Innate versus adaptive immunity in Candida albicans infection. Immunol Cell Biol 2004; 82: 196-204.
37. Bodey GP, Mardani M, Hanna HA, et al. The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer. Am J Med 2002; 112: 380-385.
38. Geerlings SE, Hoepelman AIM. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol 1999; 26: 259-265.
39. Ehlers M. RCR3: a general purpose adhesion-recognition receptor essential for innate immunity. Microbes Infect 2000; 2: 289-294.
40. Caron E, Hall A. Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases. Science 1998; 282: 1717-1721.
41. Schranz DB, Lernmark Å. Immunology in Diabetes: An Update. Diabetes Metab Rev 1998; 14: 3-29.
42. Wilson RM, Reeves WG. Neutrophil phagocytosis and killing in insulin-dependent diabetes. Clin Exp Immunol 1986; 63: 478-484.
43. Vlassara H, Bucala R, Striker L. Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest 1994; 70: 138-151.
44. Aratani Y, Koyama H, Nyui S, Suzuki K, Kura F, Maeda N. Severe impairment in early host defense against Candida albicans in mice deficient in myeloperoxidase. Infect Immun 1999; 67: 1828-1836.